PMAIP1 and mantle cell lymphoma: Collectively, these data demonstrate that the combination of bortezomib with a FASNi provides a potent tool to effectively induce MCL cell death via super-induction of NOXA presumably by parallel inhibition of the proteasome as well as the autophagic degradation machinery.